Editas Medicine, Inc. Common Stock (EDIT) News
Latest headlines that mention EDIT, newest first · each headline opens the original publisher
- Last price
- $2.40
- Day change
- +0.00%
- Next earnings
- 2026-11-09
EDIT headlines
latest coverageNot much coverage yet. EDIT has appeared in only a few headlines lately; new stories show up here as publishers cover it.
One company dominates with an approved therapy, while the other bets on in vivo innovation. See how their financials and risk profiles stack up for 2026.
EDIT news alerts
Get an alert by email or push when a new headline mentions EDIT.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.